Effects of cannabinoid receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys

European Journal of Pharmacology

Volumn 633, Issue 1-3, 2010, Pages 44-49

  Schindler, Charles W ^a   Panlilio, Leigh V ^a   Gilman, Joanne P ^a   Justinova, Zuzana ^a,b   Vemuri, V Kiran ^c   Makriyannis, Alex ^c   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Cannabinoid; Methamphetamine; Receptor antagonist; Reinstatement; Rhesus monkey; Self administration

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID RECEPTOR ANTAGONIST; METHAMPHETAMINE; RIMONABANT;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SELF ADMINISTRATION; FEMALE; FOOD; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY;

ANIMALS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; FEMALE; MACACA MULATTA; MALE; METHAMPHETAMINE; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECURRENCE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 77949917886     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.02.005     Document Type: Article

References (27)

1. Anggadiredja K., Nakamichi M., Hiranita T., Tanaka H., Shoyama Y., Watanabe S., Yamamoto T. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology 2004, 29:1470-1478.
2. Beardsley P.M., Thomas B.F., McMahon L.R. Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders. Int. Rev. Psychiatry 2009, 21:134-142.
3. Boctor S.Y., Martinez J.L., Koek W., France C.P. The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding. Eur. J. Pharmacol. 2007, 571:39-43.
4. De Vries T.J., Shaham Y., Homberg J.R., Crombag H.S., Schuurman K., Dieben J., Vanderschuren L.J., Schoffelmeer A.N. A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 2001, 7:1151-1154.
5. Fattore L., Fadda P., Fratta W. Endocannabinoid regulation of relapse mechanisms. Pharmacol. Res. 2007, 56:418-427.
6. Filip M., Gołda A., Zaniewska M., McCreary A.C., Nowak E., Kolasiewicz W., Przegaliński E. Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharmacol. Rep. 2006, 58:806-819.
7. Justinova Z., Tanda G., Redhi G., Goldberg S. Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology 2003, 169:135-140.
8. Justinova Z., Solinas M., Tanda G., Redhi G., Goldberg S. The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. J. Neurosci. 2005, 25:5645-5650.
9. Justinova Z., Munzar P., Panlilio L., Yasar S., Redhi G.H., Tanda G., Goldberg S.R. Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant. Neuropsychopharmacology 2008, 33:2870-2877.
10. Katz J.L., Higgins S.T. The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology (Berl) 2003, 168:21-30.
11. Khroyan T.V., Barrett-Larimore R.L., Rowlett J.K., Spealman R.D. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J. Pharmacol. Exp. Ther. 2000, 294:680-687.
12. Lan R., Liu Q., Fan P., Lin S., Fernando S.R., McCallion D., Pertwee R., Makriyannis A. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 1999, 42:769-776.
13. Le Foll B., Goldberg S. Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J. Pharmacol. Exp. Ther. 2005, 312:875-883.
14. Lesscher H.M., Hoogveld E., Burbach J.P., van Ree J.M., Gerrits M.A. Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur. Neuropsychopharmacol. 2005, 15:31-37.
15. Madsen M.V., Peacock L., Werge T., Andersen M.B. Effects of the cannabinoid CB1 receptor agonist CP55, 940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys. J. Psychopharmacol. 2006, 20:622-628.
16. Meschler J.P., Howlett A.C. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 2001, 40:918-926.
17. O'Brien C.P., Childress A.R., Arndt I.O., McLellan A.T., Woody G.E., Maany I. Pharmacological and behavioral treatments of cocaine dependence: controlled studies. J. Clin. Psychiatry 1988, 49:17-22. Suppl.
18. Ong W.Y., Mackie K. A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 1999, 92:1177-1191.
19. Pertwee R.G. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci. 2005, 76:1307-1324.
20. Solinas M., Yasar S., Goldberg S. Endocannabinoid system involvement in brain reward processes related to drug abuse. Pharmacol. Res. 2007, 56:393-405.
21. Tallett A.J., Blundell J.E., Rodgers J.R. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM251 in rats: indirect behavioural mediation. Behav. Pharmacol. 2007, 18:591-600.
22. Tanda G. Modulation of the endocannabinoid system: therapeutic potential against cocaine dependence. Pharmacol. Res. 2007, 56:406-417.
23. Tanda G., Munzar P., Goldberg S.R. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat. Neurosci. 2000, 3:1073-1074.
24. Tzavara E.T., Degroot A., Wade M.R., Davis R.J., Nomikos G.G. CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: role of mGlu5 receptors. Eur. Neuropsychopharmacol. 2009, 19:196-204.
25. Vinklerová J., Nováková J., Sulcová A. Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. J. Psychopharmacol. 2002, 16:139-143.
26. Xi Z., Gilbert J., Peng X.Q., Pak A., Li X., Gardner E. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J. Neurosci. 2006, 26:8531-8536.
27. Xi Z., Spiller K., Pak A., Gilbert J., Dillon C., Li X., Peng X.Q., Gardner E. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology 2008, 33:1735-1745.